Anti-TNF antibodies in inflammatory bowel disease: do we finally know how it works?

Current drug targets

Volumn 14, Issue 12, 2013, Pages 1421-1432

  Oikonomopoulos, Angelos ^a   van Deen, Welmoed K ^b   Hommes, Daniel W ^b  

^a Ueberoth   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES; APOPTOSIS; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899122934     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113149990164     Document Type: Review

References (0)